Aduro Biotech Inc.

(ADRO) Trade

By |

Profile

Aduro Biotech Inc is a immunotherapy company focused on the discovery, development and commercialization of therapies that are designed to harness the body's natural immune system for the treatment of patients with challenging diseases. Its primary technologies related are to the Stimulator of Interferon Genes (STING) and A Proliferation Inducing Ligand. The STING pathway activator technology is designed to activate the intracellular STING receptor. The APRIL is a soluble factor that binds to BCMA and TACI receptors thereby inducing signaling, and is implicated in IgA nephropathy.

Contact Information

Website: www.aduro.com
Email: investors@aduro.com
Main Phone: +1 510 848-4400
Address: 740 Heinz Avenue
State: CA
City / Town: Berkeley
Country: USA
Postal Code: 94710

Issuer Information

Exchange: NGS
CEO: Stephen T. Isaacs
Employees: 152
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News



Gathering Data... Please wait

Profile

Aduro Biotech Inc is a immunotherapy company focused on the discovery, development and commercialization of therapies that are designed to harness the body's natural immune system for the treatment of patients with challenging diseases. Its primary technologies related are to the Stimulator of Interferon Genes (STING) and A Proliferation Inducing Ligand. The STING pathway activator technology is designed to activate the intracellular STING receptor. The APRIL is a soluble factor that binds to BCMA and TACI receptors thereby inducing signaling, and is implicated in IgA nephropathy.

Contact Information

Website: www.aduro.com
Email: investors@aduro.com
Main Phone: +1 510 848-4400
Address: 740 Heinz Avenue
State: CA
City / Town: Berkeley
Country: USA
Postal Code: 94710

Issuer Information

Exchange: NGS
CEO: Stephen T. Isaacs
Employees: 152
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 1.00 $ 0.0124 (1.26%)
Last Price 1.00 Change $ 0.0124 Change % 1.26 Tick N/A
Bid 0.99 Bid Size 1,000.00 Ask 1.01 Ask Size 1,300.00
Open 0.98 High 1.01 Low 0.96 Prev Close 0.99
Last Trade Volume 421,148 52 Wk Hi 6.94 52 Wk Low 0.92
Market Cap 80.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 80,140,274.00 EPS (TTM) -1.14 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 8 142
Number of Buys 4 79
Number of Sells 4 63
Net Activity -2000 415748
Last 10 Buys Shares
Stephanie Monaghan O¿Brien 1,000
Stephanie Monaghan O¿Brien 1,000
Jennifer Lew 1,000
William M. Greenman 1,000
Last 10 Sell Shares
Stephen T. Isaacs 1,000
Blaine Templeman 1,000
Stephen T. Isaacs 1,000
Stephen T. Isaacs 1,000
Stephen T. Isaacs 1,000
Stephen T. Isaacs 1,000
Stephen T. Isaacs 1,000
Elsas Andrea Van 1,000
Stephen T. Isaacs 1,000
Gregory W. Schafer 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 15 15 15 15
Low Target Price Estimate 8 8 8 8
Mean Target Price Estimate 11.38 11.38 11.38 11.38
Standard Deviation 3.2 3.2 3.2 3.2
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 6
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 1.5 1.5 1.5 1.43